| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| PNB Metlife India Insurance Company Limited |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | 61,467.14 | 55,045.65 | 48,583.28 | 40,683.07 | 35,253.35 |
| Total equity | 2,681.74 | 2,059.00 | 2,019.58 | 2,017.12 | 2,025.96 |
| Total liabilities | 58,785.40 | 52,987.00 | 46,563.70 | 38,665.95 | 33,227.38 |
| ASSETS | 61,467.14 | 55,045.65 | 48,583.28 | 40,683.07 | 35,253.35 |
| Non-Current assets | 61,264.72 | 54,673.00 | 48,116.82 | 40,127.09 | 34,660.31 |
| Current assets | 202.42 | 372.70 | 182.60 | -3.53 | -78.66 |
| Debit Balance in Profit and Loss Account | 0.00 | 0.00 | 283.86 | 559.52 | 671.70 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Net cash from/(used in) operating activities | 3,583.74 | 3,255.27 | 2,379.62 | 3,369.13 | 2,343.43 |
| Net cash from/(used in) investing activities | -3,746.85 | -3,155.22 | -2,353.31 | -3,259.22 | -2,895.02 |
| Net cash from/(used) in financing activities | 267.52 | -32.48 | -32.48 | -32.48 | 400.00 |
| Net increase /(decrease) in cash and cash equivalents | 104.41 | 67.57 | -6.17 | 77.43 | -151.59 |
| Cash and cash equivalents at the beginning of the year | 189.95 | 122.38 | 128.55 | 51.12 | 202.71 |
| Cash and cash equivalents at the end of the year | 294.36 | 189.95 | 122.38 | 128.55 | 51.12 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Revenue | 640.24 | 626.76 | 384.99 | 242.27 | 174.76 |
| Revenue from operations | 640.24 | 626.76 | 237.69 | 107.00 | 53.23 |
| Other income | 147.30 | 135.27 | 121.53 | ||
| Expenses | 320.32 | 301.42 | 95.81 | 119.19 | 245.80 |
| Expenses other than those directly related to th... | 9.06 | 8.07 | 14.34 | 13.15 | 10.31 |
| Interest on non-convertible debentures | 32.48 | 32.29 | 32.57 | 32.48 | 5.61 |
| Profit/(loss) before tax | 319.92 | 325.35 | 289.18 | 123.08 | -71.04 |
| Tax Expense | 13.53 | 10.89 | 0.00 | ||
| Profit (Loss) for the period from continuing Operations | 319.92 | 325.35 | 275.66 | 112.19 | -71.04 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Revenue | 640.24 | 626.76 | 384.99 | 242.27 | 174.76 |
| Total Expense | 9.06 | 301.42 | 95.81 | 119.19 | 245.80 |
| Net Worth | 2,681.74 | 2,059.04 | 2,019.58 | 2,017.12 | 2,025.96 |
| Taxes | 0.00 | 0.00 | 13.53 | 10.89 | 0.00 |
| Outstanding Shares | 2,049,469,646.00 | 2,012,884,283.00 | 2,012,884,283.00 | 2,012,884,283.00 | 2,012,884,283.00 |
| Earnings Per Share (EPS) | 1.56 | 1.62 | 1.37 | 0.56 | -0.35 |
| Total Assets | 61,467.14 | 55,045.65 | 48,583.28 | 40,683.07 | 35,253.35 |
| Total Liabilites | 58,785.40 | 52,986.61 | 46,563.70 | 38,665.95 | 33,227.38 |
| Total equity | 2,681.74 | 2,059.04 | 2,019.58 | 2,017.12 | 2,025.96 |
| Net cash from/(used in) operating activities | 3,583.74 | 3,255.27 | 2,379.62 | 3,369.13 | 2,343.43 |
| Net cash from/(used in) investing activities | -3,746.85 | -3,155.22 | -2,353.31 | -3,259.22 | -2,895.02 |
| Net cash from/(used) in financing activities | 267.52 | -32.48 | -32.48 | -32.48 | 400.00 |
